NEJM publishes final results from phase two study showing vaccines can reduce rate of sustained TB infections

(Burness) Aeras, a nonprofit organization dedicated to developing vaccines against tuberculosis (TB), today announced the publication of the full results from a Phase 2, randomized, controlled clinical trial of two TB vaccines-- the currently available BCG vaccine and an investigational vaccine, H4:IC31--in the New England Journal of Medicine (NEJM).
Source: EurekAlert! - Infectious and Emerging Diseases - Category: Infectious Diseases Source Type: news